Michael J. Fox has been named the recipient of the 2026 Lasker~Bloomberg Public Service Award, a prestigious honor recognizing his transformative leadership in Parkinson’s disease advocacy and research. The announcement, made on September 9, highlights the significant impact of the Michael J. Fox Foundation (MJFF) in accelerating medical breakthroughs since its inception in 2000.
The award, often referred to as “America’s Nobel,” acknowledges Fox’s role in shifting the focus of Parkinson’s research toward patient-centered outcomes and large-scale collaborative science. A primary achievement noted in his advocacy is the development of the alpha-synuclein seed amplification assay, a biological marker that allows for the earlier and more accurate detection of the disease.
Expanding Research and Fundraising Goals
The Lasker Foundation is scheduled to hold the official award ceremony in New York City on September 17, 2026. The recognition comes as the MJFF reaches a major financial milestone, having funded more than $3 billion in Parkinson’s research to date. Following this achievement, the foundation has launched a new campaign seeking to raise an additional $2.5 billion to further accelerate the search for a cure.
This fundraising drive coincides with a new public awareness effort. On September 2, 2026, Fox appeared alongside Harrison Ford in a campaign titled “So… Your Friend Has Parkinson’s,” designed to help the public navigate social interactions and support systems for those living with the condition.
Return to Acting in ‘Shrinking’
Beyond his advocacy, Fox is returning to television in a role that mirrors his real-world experiences. He has joined the cast of the Apple TV+ series Shrinking for its third season, playing a character named Gerry who also lives with Parkinson’s disease. This role marks a notable appearance for Fox, allowing him to portray the nuances of the condition within a scripted narrative.
Fox’s recent developments represent a dual focus on scientific progress and cultural representation. While the MJFF continues to fund high-stakes research, his creative and collaborative projects aim to increase the visibility of the Parkinson’s community. The Lasker Award serves as a validation of this long-term strategy, which has moved the field from fragmented studies to a unified, well-funded scientific movement.
